atriva-therapeutics.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-Agent: * Allow: /wp-content/uploads/ Disallow: /wp-content/plugins/ Disallow: /wp-admin/ Disallow: /artgerecht-login/ Disallow: /store/ Sitemap:
Meta Tags
Title Atriva Therapeutics |
Description Atriva TherapeuticsWhen prevention fails: host-targeting therapy for severe viral Therapies against viral infections. First-in-class host-targeting therapies to treat respiratory viral infections, including COVID-19 and
Keywords N/A
Server Information
WebSite atriva-therapeutics faviconatriva-therapeutics.com
Host IP 62.220.18.183
Location Germany
Related Websites
Site Rank
More to Explore
avetexfurniture.com
avijatrik.org
baldface.com
baltimorehardware.com
bambinoagro.com
bamfcustomcreations.com
bandhu.eu
batterylowinteractive.com
bei.edu
bentranspvtltd.com
betterhempcompany.com
birdaddicts.com
bookminders.com
borisolhor.com
broaddusassociates.com
buyyurbuds.com
buyzenk.com
canambioresearch.com
catalo.us
clippingpath360.com
atriva-therapeutics.com Valuation
US$2,260,060
Last updated: 2023-05-01 03:58:04

atriva-therapeutics.com has Semrush global rank of 4,683,197. atriva-therapeutics.com has an estimated worth of US$ 2,260,060, based on its estimated Ads revenue. atriva-therapeutics.com receives approximately 260,777 unique visitors each day. Its web server is located in Germany, with IP address 62.220.18.183. According to SiteAdvisor, atriva-therapeutics.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$2,260,060
Daily Ads Revenue US$2,087
Monthly Ads Revenue US$62,587
Yearly Ads Revenue US$751,036
Daily Unique Visitors 17,386
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
atriva-therapeutics.com. 3599 A atriva-therapeutics.com. 3599 IP: 62.220.18.183
atriva-therapeutics.com. 3600 NS atriva-therapeutics.com. 3600 NS Record: d.ns14.net.
atriva-therapeutics.com. 3600 NS atriva-therapeutics.com. 3600 NS Record: c.ns14.net.
atriva-therapeutics.com. 3600 NS atriva-therapeutics.com. 3600 NS Record: b.ns14.net.
atriva-therapeutics.com. 3600 NS atriva-therapeutics.com. 3600 NS Record: a.ns14.net.
atriva-therapeutics.com. 3600 MX atriva-therapeutics.com. 3600 MX Record: 0 atrivatherapeutics-com01e.mail.protection.outlook.com.
atriva-therapeutics.com. 3600 TXT atriva-therapeutics.com. 3600 TXT Record: MS=ms94524175
atriva-therapeutics.com. 3600 TXT atriva-therapeutics.com. 3600 TXT Record: v=spf1 include:spf.protection.outlook.com include:mailing.eqs.com -all
HtmlToTextCheckTime:2023-05-01 03:58:04
Zum Inhalt springen About us Company Management Advisory Board Scientific Board Atriva Therapeutics founded in 2015, is a clinical-stage biopharmaceutical company pioneering the development of host -cell -targeting therapies against viral infections . Read more The Atriva Approach Investors Indications News Scientific Publications Contact Navigations-Menü Navigations-Menü About us Company Management Advisory Board Scientific Board The Atriva Approach Investors Indications News Scientific Publications Contact Atriva Therapeutics When prevention fails: host-targeting therapy for severe viral disease More Info The Atriva Approach First-in-class host-targeting therapies to treat infections caused for example by influenza viruses, respiratory syncytial virus, dengue fever virus and hanta virus. Great potential against a wide variety of respiratory viruses due to antiviral and immunomodulating activity of ATRIVA’s lead product zapnometinib (INN). Phase I successfully completed. RESPIRE
HTTP Headers
HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Sat, 23 Oct 2021 19:34:01 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Location: https://atriva-therapeutics.com/

HTTP/2 200 
server: nginx
date: Sat, 23 Oct 2021 19:34:02 GMT
content-type: text/html; charset=UTF-8
x-powered-by: PHP/7.4.16
expires: Thu, 19 Nov 1981 08:52:00 GMT
cache-control: no-store, no-cache, must-revalidate
pragma: no-cache
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
set-cookie: PHPSESSID=al519frrell1f3l79e5ogrksbl; path=/
strict-transport-security: max-age=15768000; includeSubDomains
x-powered-by: PleskLin
atriva-therapeutics.com Whois Information
Domain Name: ATRIVA-THERAPEUTICS.COM
Registry Domain ID: 1932574557_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.psi-usa.info
Registrar URL: http://www.psi-usa.info
Updated Date: 2021-05-27T07:10:30Z
Creation Date: 2015-05-26T11:19:07Z
Registry Expiry Date: 2022-05-26T11:19:07Z
Registrar: PSI-USA, Inc. dba Domain Robot
Registrar IANA ID: 151
Registrar Abuse Contact Email: domain-abuse@psi-usa.info
Registrar Abuse Contact Phone: +49.94159559482
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: A.NS14.NET
Name Server: B.NS14.NET
Name Server: C.NS14.NET
Name Server: D.NS14.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-12T05:29:35Z <<<